|
Quotes & Info
|
| VPHM > SEC Filings for VPHM > Form 8-K on 16-Dec-2008 | All Recent SEC Filings |
16-Dec-2008
Other Events, Financial Statements and Exhibits
On December 15, 2008, ViroPharma Incorporated provided an update on Vancocin based upon the draft guidance on bioequivalence issued by the U.S. Food and Drug Administration. The full text of the press release issued in connection with the announcement is set forth as Exhibit 99.1 attached hereto.
The following exhibits are attached to this Form 8-K:
(d) Exhibit No. Description
99.1 Press release dated December 15, 2008.
|
|